Relay Therapeutics, Inc. — All Filings
487 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B4
424B5
424B7
5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
PRE 14A
S-1
S-1/A
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-002139 | Mar 27, 2026 | — |
| SCHEDULE 13G | — | 0001193125-26-115967 | Mar 19, 2026 | — |
| 8-K | 8-K | 0001193125-26-107312 | Mar 16, 2026 | — |
| 4 | 4 | 0001193125-26-102270 | Mar 11, 2026 | Mar 9, 2026 |
| 8-K | 8-K | 0001193125-26-102178 | Mar 11, 2026 | Mar 6, 2026 |
| 144 | — | 0001950047-26-002370 | Mar 9, 2026 | — |
| S-8 | S-8 | 0001193125-26-076900 | Feb 26, 2026 | — |
| 10-K | 10-K | 0001193125-26-076739 | Feb 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-076617 | Feb 26, 2026 | — |
| SCHEDULE 13G/A | — | 0000919574-26-001221 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0000919574-26-001220 | Feb 17, 2026 | — |
| 8-K | 8-K | 0001193125-26-034422 | Feb 3, 2026 | — |
| 4 | 4 | 0001193125-26-029415 | Jan 29, 2026 | Jan 27, 2026 |
| 4 | 4 | 0001193125-26-029412 | Jan 29, 2026 | Jan 27, 2026 |
| 4 | 4 | 0001193125-26-029403 | Jan 29, 2026 | Jan 27, 2026 |
| 4 | 4 | 0001193125-26-014111 | Jan 15, 2026 | Jan 13, 2026 |
| 4 | 4 | 0001193125-26-014110 | Jan 15, 2026 | Jan 13, 2026 |
| 4 | 4 | 0001193125-26-014109 | Jan 15, 2026 | Jan 13, 2026 |
| 4 | 4 | 0001193125-26-014106 | Jan 15, 2026 | Jan 13, 2026 |
| 4 | 4 | 0001193125-26-006328 | Jan 7, 2026 | Jan 6, 2026 |
| SCHEDULE 13G/A | — | 0001831942-25-000024 | Nov 14, 2025 | — |
| 4 | 4 | 0001193125-25-269790 | Nov 6, 2025 | Nov 4, 2025 |
| 4 | 4 | 0001193125-25-269769 | Nov 6, 2025 | Nov 4, 2025 |
| 3 | 3 | 0001193125-25-269711 | Nov 6, 2025 | Nov 4, 2025 |
| 3 | 3 | 0001193125-25-269707 | Nov 6, 2025 | Nov 4, 2025 |
| 10-Q | 10-Q | 0001193125-25-269601 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-269536 | Nov 6, 2025 | Nov 4, 2025 |
| 4 | 4 | 0001193125-25-264700 | Nov 4, 2025 | Nov 3, 2025 |
| 4 | 4 | 0001193125-25-258595 | Oct 30, 2025 | Oct 28, 2025 |
| 4 | 4 | 0001193125-25-258574 | Oct 30, 2025 | Oct 28, 2025 |
| 4 | 4 | 0001193125-25-258557 | Oct 30, 2025 | Oct 28, 2025 |
| 144 | — | 0001950047-25-008255 | Oct 29, 2025 | — |
| SCHEDULE 13G/A | — | 0001831942-25-000014 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-003691 | Aug 14, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-105054 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-105022 | Aug 7, 2025 | — |
| 4 | 4 | 0000950170-25-100367 | Jul 30, 2025 | Jul 28, 2025 |
| 4 | 4 | 0000950170-25-100366 | Jul 30, 2025 | Jul 28, 2025 |
| 4 | 4 | 0000950170-25-100365 | Jul 30, 2025 | Jul 28, 2025 |
| 4 | 4 | 0000950170-25-100364 | Jul 30, 2025 | Jul 28, 2025 |
| SCHEDULE 13G/A | — | 0000932471-25-000992 | Jul 29, 2025 | — |
| 4 | 4 | 0000950170-25-095093 | Jul 10, 2025 | Jul 9, 2025 |
| 4 | 4 | 0000950170-25-092315 | Jul 1, 2025 | Jun 30, 2025 |
| 4 | 4 | 0000950170-25-092305 | Jul 1, 2025 | Jun 30, 2025 |
| 4 | 4 | 0000950170-25-084838 | Jun 11, 2025 | Jun 9, 2025 |
| 3 | 3 | 0000950170-25-084836 | Jun 11, 2025 | Jun 9, 2025 |
| 8-K | 8-K | 0001193125-25-139146 | Jun 11, 2025 | Jun 8, 2025 |
| 4 | 4 | 0000950170-25-083314 | Jun 6, 2025 | — |
| 4 | 4 | 0000950170-25-083312 | Jun 6, 2025 | — |
| 4 | 4 | 0000950170-25-083311 | Jun 6, 2025 | — |